This under-the-radar market trend suggests new record highs through December

Finance

Even though stocks are trading around all-time highs, CFRA’s Sam Stovall thinks Wall Street isn’t bullish enough.

According to the firm’s chief investment strategist, an under-the-radar historical trend suggests the S&P 500 will continue to reach record levels through December. He credits a phenomenon that’s only happened 28 times since WWII.

Stovall highlighted the pattern in a chart on CNBC’s “Trading Nation.”

“There’s something special about this year. We had a positive move in the market in both January and February,” Stovall said on Thursday. “February is the second worst month of the year — second only to September. It’s usually a digestive month.”

When the market is up the first two months of the year, Stovall notes the S&P has been up 100% of the time. He estimates the average total return is 24% for the full year. So far this year, the index is up 24.4%.

However, that doesn’t mean market gains are in for 2019.

Stovall points to another unusual characteristic of the year’s record run: Stocks hit highs this month, too.

“Throw in a new all-time high in early November and you’re essentially flat to higher 11 of 11 times,” he added.

Stovall came into 2019 with a 2,975 year-end S&P price target — about 5% below Friday’s close of 3,120, a record high. He’s now focused more on his 12 month rolling target of 3,200.

The Dow also hit a milestone on Friday. It closed above 28,000 for the first time ever.

Despite his upbeat forecast, he acknowledges some risks lie ahead.

“If you end up with a strong end of year run that could be borrowing a bit from what we would expect in 2020,” Stovall said. “So, as I frequently say, I call myself a bull with a lower case ‘b.'”

Note: The S&P 500 was created in 1957 from back-tested data.

Disclaimer

Articles You May Like

MicroStrategy shares jump as bitcoin proxy will join Nasdaq-100 index and ‘QQQ’ ETF
The Fed cut interest rates but mortgage costs jumped. Here’s why
New Proposal Would Require Insurance Agents To Disclose More About Medicare Advantage Plans
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.
How Older Workers Can Overcome A Stalled Career And Stay Ahead

Leave a Reply

Your email address will not be published. Required fields are marked *